[HTML][HTML] A role of FDG-PET/CT for response evaluation in metastatic breast cancer?

MG Hildebrandt, M Naghavi-Behzad… - Seminars in Nuclear …, 2022 - Elsevier
Breast cancer prognosis is steadily improving due to early detection of primary cancer in
screening programs and revolutionizing treatment development. In the metastatic setting …

[HTML][HTML] Influences on PET quantification and interpretation

JMM Rogasch, F Hofheinz, L van Heek, CA Voltin… - Diagnostics, 2022 - mdpi.com
Various factors have been identified that influence quantitative accuracy and image
interpretation in positron emission tomography (PET). Through the continuous introduction …

[HTML][HTML] 2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer

M Vogsen, M Naghavi-Behzad, FG Harbo… - Scientific Reports, 2023 - nature.com
This study aimed to compare CE-CT and 2-[18F] FDG-PET/CT for response monitoring
metastatic breast cancer (MBC). The primary objective was to predict progression-free and …

[HTML][HTML] FDG-PET/CT for response monitoring in metastatic breast cancer: the feasibility and benefits of applying PERCIST

M Vogsen, JL Bülow, L Ljungstrøm, HR Oltmann… - Diagnostics, 2021 - mdpi.com
Background: We aimed to examine the feasibility and potential benefit of applying PET
Response Criteria in Solid Tumors (PERCIST) for response monitoring in metastatic breast …

[HTML][HTML] Innovations in positron emission tomography and state of the art in the evaluation of breast cancer treatment response

L Castorina, AD Comis, A Prestifilippo… - Journal of Clinical …, 2023 - mdpi.com
The advent of hybrid Positron Emission Tomography/Computed Tomography (PET/CT) and
PET/Magnetic Resonance Imaging (MRI) scanners resulted in an increased clinical …

[HTML][HTML] Clinical impact of FDG-PET/CT compared with CE-CT in response monitoring of metastatic breast cancer

M Naghavi-Behzad, HR Oltmann, TA Alamdari… - Cancers, 2021 - mdpi.com
Simple Summary The method of treatment evaluation in patients with chronic breast cancer
may affect clinical decision making and treatment protocols. In this study, we compared the …

[HTML][HTML] Increased lesion detectability in patients with locally advanced breast cancer—A pilot study using dynamic whole-body [18F]FDG PET/CT

MA Pedersen, AH Dias, K Hjorthaug, LC Gormsen… - EJNMMI research, 2024 - Springer
Background Accurate diagnosis of axillary lymph node (ALN) metastases is essential for
prognosis and treatment planning in breast cancer. Evaluation of ALN is done by ultrasound …

[HTML][HTML] Comparison of Image Quality and Quantification Parameters between Q. Clear and OSEM Reconstruction Methods on FDG-PET/CT Images in Patients with …

M Naghavi-Behzad, M Vogsen, O Gerke… - Journal of …, 2023 - mdpi.com
We compared the image quality and quantification parameters through bayesian penalized
likelihood reconstruction algorithm (Q. Clear) and ordered subset expectation maximization …

An evaluation of the response to neoadjuvant chemotherapy for osteosarcoma of extremities: PERCIST versus RECIST 1.1 criteria after long-term follow-up

J Xu, Y Li, L Xie, X Sun, Z Cai, S Wang, Q Wang… - Annals of Nuclear …, 2022 - Springer
Objective The aim of this study was to compare the recent Positron emission tomography
(PET) Response Criteria in Solid Tumors (PERCIST) and Response Evaluation Criteria in …

[PDF][PDF] Influences on PET Quantification and Interpretation. Diagnostics 2022, 12, 451

JMM Rogasch, F Hofheinz, L van Heek… - Quantitative PET and …, 2022 - mdpi.com
Various factors have been identified that influence quantitative accuracy and image
interpretation in positron emission tomography (PET). Through the continuous introduction …